Product: Diltiazem HCl Extended-release Capsules, USP, 120 mg, packaged in 80 Capsules (8 x 10) blister cards per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV  26505, NDC 51079-947-08.
Reason for recall: Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.
Recall initiated: 20140703
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated